According to Global Blue Group's latest financial reports the company's current EPS (TTM) is ยฃ0.28. an increase over its 2023 EPS that were of -ยฃ0.09761.
Year | EPS | Change |
---|---|---|
2024 | ยฃ0.04849 | -149.68% |
2023 | -ยฃ0.09761 | -75.97% |
2022 | -ยฃ0.41 | -79.71% |
2021 | -ยฃ2.00 | 11935.17% |
2020 | -ยฃ0.01664 | -297.97% |
2019 | ยฃ0.008405 | -89.81% |
2018 | ยฃ0.08251 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
![]() Boston Scientific BSX | ยฃ1.03 | 267.24% | ๐บ๐ธ USA |
![]() Stryker Corporation SYK | ยฃ5.61 | 1,893.19% | ๐บ๐ธ USA |
![]() Edwards Lifesciences EW | ยฃ5.25 | 1,765.45% | ๐บ๐ธ USA |
![]() Medtronic MDT | ยฃ2.47 | 778.17% | ๐ฎ๐ช Ireland |
![]() Johnson & Johnson JNJ | ยฃ6.79 | 2,313.03% | ๐บ๐ธ USA |